nicotine has been researched along with tamoxifen in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 11 (50.00) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Hendrickx, AG | 1 |
| Dehal, SS; Katchamart, S; Kupfer, D; Stresser, DM; Williams, DE | 1 |
| Braun, A; Cashman, JR; Leushner, J; Zhang, J | 1 |
| Dehal, SS; Katchamar, S; Kupfer, D; Larsen-Su, SA; Stresser, DM; Williams, DE | 1 |
| Liu, L; Qiao, Z; Wang, L; Wang, Y; Wang, Z; Yao, C; Zhao, Y; Zhou, Y | 1 |
| Lau, WB; Qiao, ZD; Wang, LL; Wang, YJ; Zhang, YQ; Zhao, JL | 1 |
| Pogun, S; Yararbas, G | 1 |
| Adams, E; Deng, X; Dogrukol-Ak, D; Van Schepdael, A; Yeniceli, D | 1 |
| Ghasemzadeh, Z; Rezayof, A; Sardari, M; Tajik, A | 1 |
| Baumbach, JL; McCormick, CM | 1 |
2 review(s) available for nicotine and tamoxifen
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
Disorders of fertilization, transport, and implantation.
Topics: Animals; Cadmium; Cadmium Chloride; Estrogens; Female; Fertilization; Fetal Death; Humans; Lead; Mice; Microwaves; Nicotine; Noise; Ovum Transport; Plants; Polychlorinated Biphenyls; Pregnancy; Rats; Tamoxifen | 1984 |
20 other study(ies) available for nicotine and tamoxifen
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction.
Topics: Aniline Compounds; Animals; Cytochrome P-450 Enzyme System; Diet; Down-Regulation; Drug Interactions; Enzyme Induction; Indoles; Male; Microsomes, Liver; Nicotine; Oxygenases; Rats; Rats, Inbred F344; Tamoxifen | 2000 |
Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms.
Topics: Alleles; Amino Acid Sequence; Animals; Asian; Base Sequence; Black People; DNA Primers; Estrogen Antagonists; Female; Gene Frequency; Genotype; Haplotypes; Hispanic or Latino; Humans; Male; Mass Spectrometry; Molecular Sequence Data; Nicotine; Nicotinic Agonists; Oxygenases; Polymorphism, Genetic; Primates; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tamoxifen; White People | 2001 |
Concurrent flavin-containing monooxygenase down regulation and cytochrome P450 induction by dietary indoles in the rat: implication for drug-drug interactions.
Topics: Aniline Compounds; Animals; Anticarcinogenic Agents; Cytochrome P-450 CYP1A1; Down-Regulation; Drug Interactions; Enzyme Induction; Indoles; Liver; Male; Microsomes, Liver; Nicotine; Oxygenases; Rats; Rats, Inbred F344; Tamoxifen | 2001 |
Estrogen down-regulates nicotine-induced adhesion molecule expression via nongenomic signal pathway in endothelial cells.
Topics: Calcium Signaling; Cell Adhesion Molecules; Cells, Cultured; Chelating Agents; Down-Regulation; E-Selectin; Egtazic Acid; Endothelial Cells; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Humans; Nicotine; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Receptors, Estradiol; Tamoxifen; Vascular Cell Adhesion Molecule-1 | 2006 |
Estradiol pretreatment attenuated nicotine-induced endothelial cell apoptosis via estradiol functional membrane receptor.
Topics: Apoptosis; Calcium Signaling; Cardiovascular Diseases; Cell Line; Endothelium, Vascular; Estradiol; Female; Humans; Male; Nicotine; p38 Mitogen-Activated Protein Kinases; Patch-Clamp Techniques; Phosphorylation; Receptors, Estradiol; Risk; Sex Factors; Smoking; Tamoxifen | 2011 |
Tamoxifen and mifepriston modulate nicotine induced conditioned place preference in female rats.
Topics: Animals; Conditioning, Psychological; Female; Hormone Antagonists; Humans; Male; Mifepristone; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Smoking Cessation; Tamoxifen; Tobacco Use Disorder | 2011 |
Development of a CD-MEKC method for investigating the metabolism of tamoxifen by flavin-containing monooxygenases and the inhibitory effects of methimazole, nicotine and DMXAA.
Topics: Chromatography, Micellar Electrokinetic Capillary; Cyclodextrins; Humans; Methimazole; Nicotine; Oxygenases; Reproducibility of Results; Tamoxifen; Xanthones | 2013 |
Activation of the dorsal hippocampal nicotinic acetylcholine receptors improves tamoxifen-induced memory retrieval impairment in adult female rats.
Topics: Aging; Animals; Avoidance Learning; Female; Hippocampus; Mecamylamine; Memory; Memory Disorders; Nicotine; Nicotinic Agonists; Rats, Wistar; Receptors, Nicotinic; Tamoxifen | 2016 |
Nicotine sensitization (part 1): estradiol or tamoxifen is required during the induction phase and not the expression phase to enable locomotor sensitization to nicotine in female rats.
Topics: Animals; Behavior, Animal; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Locomotion; Nicotine; Ovariectomy; Rats; Rats, Long-Evans; Receptors, Estrogen; Receptors, G-Protein-Coupled; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors | 2021 |